LeslieElaineLehmannMD

Pediatric Hematology & Oncology • Boston, MA

Assistant Professor, Pediatrics, Children's Hospital, Harvard Medical School

Join to view full profile

Dr. Lehmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lehmann's full profile

Already have an account?

Office
44 Binney St
# Dana
Boston, MA 02115
Phone+1 617-632-4923

Fax+1 617-632-2095

Education & Training

Duke University HospitalResidency, Pediatrics, 1987 - 1992
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1985 - 1987
Duke University School of MedicineClass of 1985

Certifications & Licensure

MA State Medical License 1993 - 2026
NC State Medical License 1989 - 1998
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Completed
Phase 3
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita Start of enrollment: 2012 Jul 01
Active, not recruiting
Phase 2
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Start of enrollment: 2022 Apr 19
Recruiting
Phase 2
Roles: Principal Investigator
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant Start of enrollment: 2023 Apr 04
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Global health training opportunities during pediatric hematology/oncology fellowship: Results from a survey of program leaders.
Paula R Hornstein, Ayo S Falade, Scott A Triedman, Leslie E Lehmann, Temidayo A Fadelu
Pediatric Blood & Cancer. 2025-01-01
Quality of life and late therapy effects in pediatric non-Hodgkin lymphoma survivors: Insights from a single-institution study.
Azza Ayad, Reham Khedr, Asmaa Hamoda, Nahla Elnabarawy, Elhamy Rifky
Pediatric Blood & Cancer. 2024-12-01
Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis.
Amy Li, Sei-Gyung K Sze, Malika Kapadia, Leslie Lehmann, Jacob R Bledsoe
Pediatric Blood & Cancer. 2024-10-01

Journal Articles

Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy
Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature

Abstracts/Posters

Ten Years of Treating Chronic Myeloid Leukemia in Rural Rwanda: Feasible Approaches for Low-Resource Settings
Leslie E. Lehmann, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Report on the Treatment of Hodgkin Lymphoma with ABVD Chemotherapy at Two Rural District Hospitals in Rwanda
Leslie E. Lehmann, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Transplant Associated Thrombotic Microangiopathy (TA-TMA): Lessons Learned from a Large Pediatric Center
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Navigating Treatment Options and Communication in Relapsed Pediatric AMLJune 1st, 2024